MicroRNA therapeutics: Principles, expectations, and challenges

MicroRNAs (miRNAs) are a class of highly abundant non-co ding RNA molecules that are involved in several biological processes. Many miRNAs are often deregulated in several diseases including cancer. There is substantial interest in exploiting miRNAs for therapeutic applications. In this editorial, we briefly review current advances in the use of miRNAs or antisense oligonucleotides (antagomirs) for such therapies. One of the key issues related to therapy using miRNAs is degradation of naked particles in vivo. To overcome this limitation, delivery systems for miRNA-ba sed therapeutic agents have been developed, which hold tremendous potential for improving therapeutic outcome of cancer patients.